Fulgent Genetics Reports Third Quarter 2017 Financial Results
Revenue of $4.5 Million GAAP Loss of $1.1 million, or $0.06 per Share Non-GAAP loss of $442,000, or $0.02 per Share Adjusted EBITDA loss of $458,000 TEMPLE CITY, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ:FLGT) (“Fulgent” or the “ …